Table III.
Comparison with previous studies.
| Mutation type | NCI CTG/AGITGa (n=164) | Leuvenb (n=122) | Italianc (n=24) | This study (Japanese) (n=98) | P-value |
|---|---|---|---|---|---|
| p.G13D | 20 (12.2) | 20 (16.4) | 5 (20.8) | 23 (23.5) | P=0.11 |
| Other | 144 (87.8) | 102 (83.6) | 19 (79.2) | 75 (76.5) |
Data are presented as absolute number (percentage).
a
The National Cancer Institute of Canada Clinical Trials Group/Australasian Gastrointestinal Trials Group.
b
Leuven data set comprises EVEREST, BOND, SALVAGE and BABEL trial data.
c
Italian data set comprises BOND, MABEL and EMR202600 trial data. The data are available at http://jama.ama-assn.org/content/304/16/1812/suppl/DC1.